woman smiling at camera
Renee Wegrzyn Tapped to Head ARPA-H
As the new agency’s director, the DARPA veteran will spearhead a high-risk, high-reward approach to biomedical research.
Renee Wegrzyn Tapped to Head ARPA-H
Renee Wegrzyn Tapped to Head ARPA-H

As the new agency’s director, the DARPA veteran will spearhead a high-risk, high-reward approach to biomedical research.

As the new agency’s director, the DARPA veteran will spearhead a high-risk, high-reward approach to biomedical research.

NIH
person with lab coat and blue gloves holding tray with pink liquid <br><br>
Scientists Consider How Overturning Roe Might Affect Research
Natalia Mesa | Sep 7, 2022
Researchers who work with materials such as fetal tissue and human embryonic stem cells are facing new restrictions, the latest in a long line of regulations, that could impede important advances.
Approved grant abstract with hype words
Major, Groundbreaking Increase in Hype in Grant Applications
Christie Wilcox | Aug 30, 2022
Projects funded by the National Institutes of Health increasingly employ subjective and promotional language in describing research, a study finds.
Anthony Fauci
Anthony Fauci Announces Departure from NIAID, Advisory Roles
Catherine Offord | Aug 22, 2022
The 81-year-old director says that he will step back from his positions this December, but that he will continue working to advance science and public health.
A red sign that reads “Clinical Center, Building 10” outside of a brick building
NIH Fails to Enforce Rules for Reporting Clinical Trial Results
Amanda Heidt | Aug 18, 2022
A review by the US Office of Inspector General found that only about half of the scientists running clinical trials funded by the NIH in 2019 and 2020 appropriately recorded their findings in a federal database, as is legally required.
EXCLUSIVE
Colorful pills and capsules on a calendar background
Clinical Trial Registry Errors Undermine Transparency
Catherine Offord | Aug 2, 2022
A lack of comprehension among some researchers about how to use ClinicalTrials.gov may be hindering public access to trial information and holding up drug study results, an investigation by The Scientist finds.
Photo of Makio Murayama
Handmade Hemoglobin, 1912-2012
Dan Robitzski | Aug 1, 2022
Makio Murayama, a Japanese-American biochemist who was turned away from the Manhattan Project due to his heritage, rose to prominence for his work uncovering the link between the structure of hemoglobin and the mechanisms of sickle cell disease.
National Science Foundation headquarters building
NSF Grant Funding Is Racially Biased, Study Finds
Andy Carstens | Jul 27, 2022
A review of more than two decades of data finds racial disparities in the success rate of National Science Foundation grant proposals.
Photo of John Calhoun crouches within his rodent utopia-turned-dystopia
Universe 25, 1968–1973
Annie Melchor | May 2, 2022
A series of rodent experiments showed that even with abundant food and water, personal space is essential to prevent societal collapse.
President Biden meeting with a group of people in the oval office
Biden Orders More Research on Long COVID
Christie Wilcox | Apr 6, 2022
A new presidential memorandum requires the Department of Health and Human Services to coordinate a government-wide push to generate a research action plan for the condition.
Large brutalist concrete building
ARPA-H to Be Within NIH but Independently Managed by HHS
Natalia Mesa | Apr 1, 2022
After lobbying efforts from lawmakers and science advisors, the new, DARPA-like biomedical research agency will be a part of the National Institutes of Health, but its director will report directly to the secretary of Health and Human Services.
Updated July 27
Magnifying glass in front of a stack of files of papers
PLOS ONE Pulls Five Papers Tied to Alzheimer’s Drug Controversy
Jef Akst | Mar 31, 2022
The retracted studies were coauthored by a scientist who worked on an Alzheimer’s therapy in development by Cassava Sciences, a company reportedly under investigation for providing falsified data to the FDA.
old-fashioned, black and white alarm clock with words "the end"
Editorial: When Will This Pandemic Officially End?
Bob Grant | Mar 11, 2022
And does it even matter?
Deborah Nickerson
Genome Pioneer Deborah Nickerson Dies at 67
Amanda Heidt | Feb 9, 2022
The University of Washington researcher leveraged data from the Human Genome Project to identify genes underlying various health conditions and advance precision medicine.
aerial view of a building on the NIH campus
Lawrence Tabak Tapped to Serve as Interim NIH Head
Shawna Williams | Dec 10, 2021
The glycoprotein researcher and longtime principal deputy director of the National Institutes of Health will take over from Francis Collins on December 20.
plasma bags hospital
WHO Rejects Convalescent Plasma Treatment for COVID-19
Chloe Tenn | Dec 6, 2021
Current evidence suggests the treatment does not improve survival or reduce the need for ventilation in COVID-19 patients, the World Health Organization says.
Old man stands in front of tree, smiling at camera.
Neuroscientist Mortimer Mishkin Dies at 94
Lisa Winter | Oct 12, 2021
His work bridged the gap between psychology and neurobiology.
NIH Director Francis Collins receiving his first dose of the Moderna COVID-19 vaccine on December 2020.
Francis Collins to Retire as NIH Director by Year’s End
Christie Wilcox | Oct 5, 2021
Collins has announced his intent to step down after leading the National Institutes of Health for more than 12 years.
a pill bottle with dice spilling out
Book Excerpt from You Bet Your Life
Paul A. Offit | Sep 21, 2021
In his book’s Introduction, physician-scientist Paul A. Offit reviews the unusual constellation of circumstances around the development of COVID-19 vaccines.
women-banner
NIH Changes Extension Policy to Better Support Women PIs
Chloe Tenn | Sep 20, 2021
The revision allows more time on previous extensions due to COVID-19 and other life events such as childbirth that disproportionately impact early-career women in science.